{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T02:01:19Z","timestamp":1766023279310,"version":"3.48.0"},"reference-count":34,"publisher":"e-Century Publishing Corporation","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Clin Exp Pathol"],"DOI":"10.62347\/wleu6787","type":"journal-article","created":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T23:54:46Z","timestamp":1750809286000},"page":"245-257","source":"Crossref","is-referenced-by-count":0,"title":["Grossly visible non-invasive neoplasm of the gallbladder: method of classification and its relationship to pyloric gland adenoma"],"prefix":"10.62347","volume":"18","author":[{"given":"Miyu","family":"Ichida","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"48694","published-online":{"date-parts":[[2025]]},"reference":[{"key":"ref0","unstructured":"Klimstra DS, Lam AK, Paradis V and Schirmacher P. Tumours of the gallbladder and extrahepatic bile ducts. In WHO classification of tumours of the digestive system. 5th ed. Lyon: International Agency for Research on Cancer (IARC); 2019: 265-294."},{"key":"ref1","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1097\/PAS.0b013e318262787c","article-title":"0 cm): clinicopathologic and immunohistochemical analysis of 123 cases","volume":"36","author":"Adsay","year":"2012","unstructured":"Adsay V, Jang KT, Roa JC, Dursun N, Ohike N, Bagci P, Basturk O, Bandyopadhyay S, Cheng JD, Sarmiento JM, Escalona OT, Goodman M, Kong SY and Terry P. Intracholecystic papillary-tubular neoplasms (ICPN) of the gallbladder (neoplastic polyps, adenomas, and papillary neoplasms that are ≥ 1.0 cm): clinicopathologic and immunohistochemical analysis of 123 cases. Am J Surg Pathol 2012; 36: 1279-301.","journal-title":"Am J Surg Pathol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1097\/PAS.0000000000001237","article-title":"Intracholecystic papillary neoplasms are distinct from papillary gallbladder cancers: a clinicopathologic and exome-sequencing study","volume":"43","author":"Akita","year":"2019","unstructured":"Akita M, Fujikura K, Ajiki T, Fukumoto T, Otani K, Hirose T, Tominaga M, Itoh T and Zen Y. Intracholecystic papillary neoplasms are distinct from papillary gallbladder cancers: a clinicopathologic and exome-sequencing study. Am J Surg Pathol 2019; 43: 783-791.","journal-title":"Am J Surg Pathol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.humpath.2021.05.001","article-title":"Prognostic implications of the coexisting precursor lesion types in invasive gallbladder cancer","volume":"114","author":"Mochidome","year":"2021","unstructured":"Mochidome N, Koga Y, Ohishi Y, Miyazaki T, Matsuda R, Yamada Y, Aishima S, Nakamura M and Oda Y. Prognostic implications of the coexisting precursor lesion types in invasive gallbladder cancer. Hum Pathol 2021; 114: 44-53.","journal-title":"Hum Pathol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/s00428-020-02877-7","article-title":"Intracholecystic tubular non-mucinous neoplasm (ICTN) of the gallbladder: a clinicopathologically distinct, invasion-resistant entity","volume":"478","author":"Pehlivanoglu","year":"2021","unstructured":"Pehlivanoglu B, Balci S, Basturk O, Bagci P, Erbarut Seven I, Memis B, Dursun N, Jang KT, Saka B, Ohike N, Tajiri T, Roa JC, Sarmiento JM, Reid MD and Adsay V. Intracholecystic tubular non-mucinous neoplasm (ICTN) of the gallbladder: a clinicopathologically distinct, invasion-resistant entity. Virchows Arch 2021; 478: 435-447.","journal-title":"Virchows Arch"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.gtc.2023.10.001","article-title":"Dysplasia and early carcinoma of the gallbladder and bile ducts: terminology, classification, and significance","volume":"53","author":"Adsay","year":"2024","unstructured":"Adsay NV and Basturk O. Dysplasia and early carcinoma of the gallbladder and bile ducts: terminology, classification, and significance. Gastroenterol Clin North Am 2024; 53: 85-108.","journal-title":"Gastroenterol Clin North Am"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"5359","DOI":"10.1158\/1078-0432.CCR-22-1954","article-title":"Comprehensive molecular characterization of gallbladder carcinoma and potential targets for intervention","volume":"28","author":"NA","year":"2022","unstructured":"Giraldo NA, Drill E, Satravada BA, Dika IE, Brannon AR, Dermawan J, Mohanty A, Ozcan K, Chakravarty D, Benayed R, Vakiani E, Abou-Alfa GK, Kundra R, Schultz N, Li BT, Berger MF, Harding JJ, Ladanyi M, O’Reilly EM, Jarnagin W, Vanderbilt C, Basturk O and Arcila ME. Comprehensive molecular characterization of gallbladder carcinoma and potential targets for intervention. Clin Cancer Res 2022; 28: 5359-5367.","journal-title":"Clin Cancer Res"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/j.jhep.2018.01.009","article-title":"Genomic characterization of biliary tract cancers identifies driver genes and predisposing mutations","volume":"68","author":"Wardell","year":"2018","unstructured":"Wardell CP, Fujita M, Yamada T, Simbolo M, Fassan M, Karlic R, Polak P, Kim J, Hatanaka Y, Maejima K, Lawlor RT, Nakanishi Y, Mitsuhashi T, Fujimoto A, Furuta M, Ruzzenente A, Conci S, Oosawa A, Sasaki-Oku A, Nakano K, Tanaka H, Yamamoto Y, Michiaki K, Kawakami Y, Aikata H, Ueno M, Hayami S, Gotoh K, Ariizumi SI, Yamamoto M, Yamaue H, Chayama K, Miyano S, Getz G, Scarpa A, Hirano S, Nakamura T and Nakagawa H. Genomic characterization of biliary tract cancers identifies driver genes and predisposing mutations. J Hepatol 2018; 68: 959-969.","journal-title":"J Hepatol"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"Chung T, Oh S, Won J, Park J, Yoo JE, Hwang HK, Choi GH, Kang CM, Han DH, Kim S and Park YN. Genomic and transcriptomic signatures of sequential carcinogenesis from papillary neoplasm to biliary tract cancer. J Hepatol 2025; [Epub ahead of print].","DOI":"10.1016\/j.jhep.2025.01.007"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"151723","DOI":"10.1016\/j.anndiagpath.2021.151723","article-title":"Pathological characterization of intracholecystic papillary neoplasm: a recently proposed preinvasive neoplasm of gallbladder","volume":"52","author":"Nakanuma","year":"2021","unstructured":"Nakanuma Y, Nomura Y, Watanabe H, Terada T, Sato Y, Kakuda Y, Sugino T, Ohnishi Y and Okamura Y. Pathological characterization of intracholecystic papillary neoplasm: a recently proposed preinvasive neoplasm of gallbladder. Ann Diagn Pathol 2021; 52: 151723.","journal-title":"Ann Diagn Pathol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1097\/PAS.0000000000001117","article-title":"Pyloric gland adenoma (PGA) of the gallbladder: a unique and distinct tumor from PGAs of the stomach, duodenum, and pancreas","volume":"42","author":"He","year":"2018","unstructured":"He C, Fukumura Y, Toriyama A, Ogura K, Sasahara N, Mitani K and Yao T. Pyloric gland adenoma (PGA) of the gallbladder: a unique and distinct tumor from PGAs of the stomach, duodenum, and pancreas. Am J Surg Pathol 2018; 42: 1237-1245.","journal-title":"Am J Surg Pathol"},{"key":"ref11","unstructured":"Nakanuma Y, Basturk O, Esposito I, Klimstra DS, Komuta M and Zen Y. Intraductal papillary neoplasm of the bile ducts. In: World Health Organization Classification of Digestive System Tumours. Lyon: International Agency for Research on Cancer; 2019: 279-282."},{"key":"ref12","doi-asserted-by":"publisher","first-page":"989","DOI":"10.5858\/arpa.2022-0407-RA","article-title":"Neoplastic progression in intraductal papillary neoplasm of the bile duct","volume":"148","author":"Zen","year":"2024","unstructured":"Zen Y and Akita M. Neoplastic progression in intraductal papillary neoplasm of the bile duct. Arch Pathol Lab Med 2024; 148: 989-996.","journal-title":"Arch Pathol Lab Med"},{"key":"ref13","unstructured":"UICC TNM Classification of Malignant Tumours. 8th ed. Oxford: United Kingdom Wiley Blackwell; 2017."},{"key":"ref14","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1111\/j.1365-2559.2008.03028.x","article-title":"Assessment of a HER2 scoring system for gastric cancer: results from a validation study","volume":"52","author":"Hofmann","year":"2008","unstructured":"Hofmann M, Stoss O, Shi D, Büttner R, van de Vijver M, Kim W, Ochiai A, Rüschoff J and Henkel T. Assessment of a HER2 scoring system for gastric cancer: results from a validation study. Histopathology 2008; 52: 797-805.","journal-title":"Histopathology"},{"key":"ref15","unstructured":"Ishikawa O, Ohhigashi H, Imaoka S, Nakaizumi A, Kitamura T, Sasaki Y, Shibata T, Wada A and Iwanaga T. The difference in malignancy between pedunculated and sessile polypoid lesions of the gallbladder. Am J Gastroenterol 1989; 84: 1386-90."},{"key":"ref16","unstructured":"Japanese Society for Cancer of the Colon and Rectum. Japanese Classification of Colorectal, Appendiceal, and Anal Carcinoma, 9th ed. Kanehara-shuppan, 2018."},{"key":"ref17","doi-asserted-by":"publisher","first-page":"7825","DOI":"10.1038\/sj.onc.1210594","article-title":"A role for LKB1 gene in human cancer beyond the Peutz-Jeghers syndrome","volume":"26","author":"Sanchez-Cespedes","year":"2007","unstructured":"Sanchez-Cespedes M. A role for LKB1 gene in human cancer beyond the Peutz-Jeghers syndrome. Oncogene 2007; 26: 7825-7832.","journal-title":"Oncogene"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"Omori Y, Ono Y, Morikawa T, Motoi F, Higuchi R, Yamamoto M, Hayakawa Y, Karasaki H, Mizukami Y, Unno M and Furukawa T. Serine\/Threonine Kinase 11 plays a canonical role in malignant progression of KRAS -mutant and GNAS -wild-type intraductal papillary mucinous neoplasms of the pancreas. Ann Surg 2023; 277: e384-e395.","DOI":"10.1097\/SLA.0000000000004842"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/j.ccr.2012.03.048","article-title":"LKB1\/STK11 inactivation leads to expansion of a prometastatic tumor subpopulation in melanoma","volume":"21","author":"Liu","year":"2012","unstructured":"Liu W, Monahan KB, Pfefferle AD, Shimamura T, Sorrentino J, Chan KT, Roadcap DW, Ollila DW, Thomas NE, Castrillon DH, Miller CR, Perou CM, Wong KK, Bear JE and Sharpless NE. LKB1\/STK11 inactivation leads to expansion of a prometastatic tumor subpopulation in melanoma. Cancer Cell 2012; 21: 751-64.","journal-title":"Cancer Cell"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"18905","DOI":"10.18632\/oncotarget.4305","article-title":"Underexpression of LKB1 tumor suppressor is associated with enhanced Wnt signaling and malignant characteristics of human intrahepatic cholangiocarcinoma","volume":"6","author":"Wang","year":"2015","unstructured":"Wang J, Zhang K, Wang J, Wu X, Liu X, Li B, Zhu Y, Yu Y, Cheng Q, Hu Z, Guo C, Hu S, Mu B, Tsai CH, Li J, Smith L, Yang L, Liu Q, Chu P, Chang V, Zhang B, Wu M, Jiang X and Yen Y. Underexpression of LKB1 tumor suppressor is associated with enhanced Wnt signaling and malignant characteristics of human intrahepatic cholangiocarcinoma. Oncotarget 2015; 6: 18905-18920.","journal-title":"Oncotarget"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1053\/hupa.2002.30723","article-title":"CTNNB1 mutations and beta-catenin expression in endometrial carcinomas","volume":"33","author":"Machin","year":"2002","unstructured":"Machin P, Catasus L, Pons C, Muñoz J, Matias-Guiu X and Prat J. CTNNB1 mutations and beta-catenin expression in endometrial carcinomas. Hum Pathol 2002; 33: 206-212.","journal-title":"Hum Pathol"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1016\/S0002-9440(10)63053-2","article-title":"STK11\/LKB1 Peutz-Jeghers gene inactivation in intraductal papillary-mucinous neoplasms of the pancreas","volume":"159","author":"Sato","year":"2001","unstructured":"Sato N, Rosty C, Jansen M, Fukushima N, Ueki T, Yeo CJ, Cameron JL, Iacobuzio-Donahue CA, Hruban RH and Goggins M. STK11\/LKB1 Peutz-Jeghers gene inactivation in intraductal papillary-mucinous neoplasms of the pancreas. Am J Pathol 2001; 159: 2017-22.","journal-title":"Am J Pathol"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1111\/his.14880","article-title":"Loss of function SMAD4 nonstop mutations in human cancer","volume":"82","author":"Bauer","year":"2023","unstructured":"Bauer AH, Basta DW, Hornick JL and Dong F. Loss of function SMAD4 nonstop mutations in human cancer. Histopathology 2023; 82: 1098-1104.","journal-title":"Histopathology"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1002\/cjp2.103","article-title":"Optimised ARID1A immunohistochemistry is an accurate predictor of ARID1A mutational status in gynaecological cancers","volume":"4","author":"Khalique","year":"2018","unstructured":"Khalique S, Naidoo K, Attygalle AD, Kriplani D, Daley F, Lowe A, Campbell J, Jones T, Hubank M, Fenwick K, Matthews N, Rust AG, Lord CJ, Banerjee S and Natrajan R. Optimised ARID1A immunohistochemistry is an accurate predictor of ARID1A mutational status in gynaecological cancers. J Pathol Clin Res 2018; 4: 154-166.","journal-title":"J Pathol Clin Res"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1093\/ajcp\/aqw071","article-title":"Loss of ARID1A expression presents a novel pathway of carcinogenesis in biliary carcinomas","volume":"145","author":"Sasaki","year":"2016","unstructured":"Sasaki M, Nitta T, Sato Y and Nakanuma Y. Loss of ARID1A expression presents a novel pathway of carcinogenesis in biliary carcinomas. Am J Clin Pathol 2016; 145: 815-825.","journal-title":"Am J Clin Pathol"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.humpath.2020.08.006","article-title":"Details of human epidermal growth factor receptor 2 status in 454 cases of biliary tract cancer","volume":"105","author":"Hiraoka","year":"2020","unstructured":"Hiraoka N, Nitta H, Ohba A, Yoshida H, Morizane C, Okusaka T, Nara S, Esaki M, Kishi Y and Shimada K. Details of human epidermal growth factor receptor 2 status in 454 cases of biliary tract cancer. Hum Pathol 2020; 105: 9-19.","journal-title":"Hum Pathol"},{"key":"ref27","unstructured":"Calistri D, Barzanti F, Dal Susino M, Fedriga R, Saragoni L, Bernardi L, Ricotti L and Zoli W. Correlation between p53 gene mutations and p53 protein accumulation evaluated by different methodologies. J Biol Regul Homeost Agents 2000; 14: 120-127."},{"key":"ref28","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1002\/path.5398","article-title":"Intraductal papillary neoplasms of the bile duct consist of two distinct types specifically associated with clinicopathological features and molecular phenotypes","volume":"251","author":"Aoki","year":"2020","unstructured":"Aoki Y, Mizuma M, Hata T, Aoki T, Omori Y, Ono Y, Mizukami Y, Unno M and Furukawa T. Intraductal papillary neoplasms of the bile duct consist of two distinct types specifically associated with clinicopathological features and molecular phenotypes. J Pathol 2020; 251: 38-48.","journal-title":"J Pathol"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/srep00161","article-title":"Whole-exome sequencing uncovers frequent GNAS mutations in intraductal papillary mucinous neoplasms of the pancreas","volume":"1","author":"Furukawa","year":"2011","unstructured":"Furukawa T, Kuboki Y, Tanji E, Yoshida S, Hatori T, Yamamoto M, Shibata N, Shimizu K, Kamatani N and Shiratori K. Whole-exome sequencing uncovers frequent GNAS mutations in intraductal papillary mucinous neoplasms of the pancreas. Sci Rep 2011; 1: 161.","journal-title":"Sci Rep"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1186\/s12957-020-02072-7","article-title":"Intracholecystic papillary neoplasm arising in a patient with pancreaticobiliary maljunction: a case report","volume":"18","author":"Iwasaki","year":"2020","unstructured":"Iwasaki T, Otsuka Y, Miyata Y, Einama T, Tsujimoto H, Ueno H, Ogata S and Kishi Y. Intracholecystic papillary neoplasm arising in a patient with pancreaticobiliary maljunction: a case report. World J Surg Oncol 2020; 18: 292.","journal-title":"World J Surg Oncol"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1007\/s00535-023-02024-4","article-title":"Current status of molecular diagnostic approaches using liquid biopsy","volume":"58","author":"Takahashi","year":"2023","unstructured":"Takahashi K, Takeda Y, Ono Y, Isomoto H and Mizukami Y. Current status of molecular diagnostic approaches using liquid biopsy. J Gastroenterol 2023; 58: 834-847.","journal-title":"J Gastroenterol"},{"key":"ref32","unstructured":"Yanagisawa N, Mikami T, Saegusa M and Okayasu I. More frequent beta-catenin exon 3 mutations in gallbladder adenomas than in carcinomas indicate different lineages. Cancer Res 2001; 61: 19-22."},{"key":"ref33","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1016\/j.humpath.2011.11.011","article-title":"Morphologic features, expression of gastric and intestinal mucins, and incidence of high-grade dysplasia\/carcinoma in situ and invasive carcinoma","volume":"43","author":"Albores-Saavedra J","year":"2012","unstructured":"Albores-Saavedra J, Chablé-Montero F, González-Romo MA, Ramírez Jaramillo M and Henson DE. Adenomas of the gallbladder. Morphologic features, expression of gastric and intestinal mucins, and incidence of high-grade dysplasia\/carcinoma in situ and invasive carcinoma. Hum Pathol 2012; 43: 1506-1513.","journal-title":"Hum Pathol"}],"container-title":["International Journal of Clinical and Experimental Pathology"],"original-title":[],"link":[{"URL":"https:\/\/e-century.us\/files\/ijcep\/18\/6\/ijcep0164499.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T01:56:22Z","timestamp":1766022982000},"score":1,"resource":{"primary":{"URL":"https:\/\/e-century.us\/files\/ijcep\/18\/6\/ijcep0164499.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":34,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.62347\/wleu6787","relation":{},"ISSN":["1936-2625"],"issn-type":[{"type":"electronic","value":"1936-2625"}],"subject":[],"published":{"date-parts":[[2025]]}}}